Non-stress testing for pregnant adults with diabetes
Canadian Agency for Drugs and Technologies in Health
Record ID 32011000987
English
Authors' recommendations:
Weak evidence from non-randomized studies suggests that daily to twice weekly antepartum surveillance with the nonstress test as an initial component of the protocol was generally associated with a good fetal outcome in patients with pregestational and gestational diabetes mellitus.
Details
Project Status:
Completed
Year Published:
2011
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Diabetes, Gestational
- Pregnancy
- Pregnancy in Diabetics
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.